Skip to main content

Clinical Trials Using Leflunomide

Review the clinical trials studying leflunomide on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-5 of 5

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Status: Active
Location: 8 locations
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients
Status: Active
Location: 6 locations
Leflunomide for the Treatment of PTEN-Altered Advanced Solid Tumors and Triple-Negative Breast Cancer
Status: Active
Location: Icahn School of Medicine at Mount Sinai, New York, New York
Leflunomide in Combination with Steroids for the Treatment of Acute Graft-versus-Host Disease after Donor Stem Cell Transplant for Hematologic Malignancies
Status: Active
Location: City of Hope Comprehensive Cancer Center, Duarte, California
Gemcitabine and Leflunomide in Patients with Advanced Unresectable Pancreatic Cancer
Status: Active
Location: City of Hope Comprehensive Cancer Center, Duarte, California